top of page
  • Writer's pictureKiran Dhillon

Advancing Vaccines to Prevent & Treat Cancer & Importance of Diversity in Clinical Trials


From top left to bottom right: Dr. Raymonda Johnson, Dr. Kiran Dhillon, Glorianne Jackson, Marilyn Lacy, Dr. Shaveta Vinayak, Dr. Nora Disis, and Bridgette Hempstead


This week the Cancer Vaccine Institute hosted a special program in partnership with the Akarama Foundation, Inc. and the Monarch Awards Foundation, Inc which are affiliated with chapters of the Alpha Kappa Alpha Sorority, Inc, the largest black sorority in the US. Cierra Sisters, an African-American breast (& other) cancer survivor and support organization based in Seattle, also partnered for this event. This was an educational & outreach opportunity to connect with a community that faces significant well-documented health disparities in cancer diagnosis, outcomes, and access to clinical trials.


The 90-minute virtual program entitled "Advances in Vaccines to Prevent & Treat Cancer" was held on May 30th from 4pm to 5:30pm PST. The event was moderated by Dr. Raymonda Johnson, Marilyn Lacy, and Glorianne Jackson, all alumni members of Alpha Kappa Alpha Sorority, Inc chapters.


The program featured the following speakers:

  • Dr. Nora Disis (Founder & Director), Cancer Vaccine Institute The Promise of Cancer Vaccines

  • Dr. Shaveta Vinayak (Breast Oncologist & Director of Clinical Trials), Cancer Vaccine Institute The Importance of Clinical Trials

  • Bridgette Hempstead (Founder), Cierra Sisters A Patient & Advocate Perspective

  • Dr. Kiran Dhillon (Executive Director), Cancer Vaccine Institute Staying Connected

We are grateful for the opportunity to connect with Alpha Kappa Alpha Sorority, Inc. Sorors and other members of the community! You can watch a recording of the event below.







Comentarios


Post: Blog2_Post
bottom of page